ArticleFrontiers in aging neuroscience2025
Predicting progression from amnestic mild cognitive impairment to Alzheimer's disease using longitudinal EEG data: a 12-month cohort study.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Amnestic mild cognitive impairment (aMCI), serving as a clinical precursor to Alzheimer's Disease (AD), assumes a pivotal role in the early stages of AD prevention. The longitudinal collection of data in aMCI is imperative for monitoring disease progression and guiding clinical interventions. Methods: Utilizing a prospective cohort design, we recruited aMCI individuals and conducted a one-year follow-up study. During this period, electroencephalogram (EEG) signals were systematically collected at regular intervals, resulting in four time points for each participant. Based on the follow-up outcomes, participants were stratified into progressive mild cognitive impairment (PMCI) and stable mild cognitive impairment (SMCI) groups. We extracted spectral, nonlinear, and functional connectivity features from the EEG data at three cross-sectional time points in the initial nine months and constructed longitudinal features between these cross-sectional assessments. The longitudinal features were fed into machine learning classifiers to predict one-year follow-up outcomes. Results: The dynamic trends of EEG features in SMCI and PMCI patients exhibited inconsistency. Utilizing the selected longitudinal features, the support vector machine (SVM) demonstrated the best prediction performance, achieving an accuracy of 94.92%, an area under the curve of 93.25%, a sensitivity of 90.20%, a specificity of 98.80%, a positive predictive value of 98.70%, and an F1-score of 93.65%. Discussion: By capturing trend information associated with disease progression, longitudinal EEG features contributed to enhancing prediction performance in machine learning models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.